丽珠医药集团股份有限公司丽 珠 Ｂ2002年中期报告（英文版）

1 LIVZON PHARMACEUTICAL GROUP INC. 2002 ANNUAL REPORT I. IMPORTANT NOTES The Board of Directors of Livzon Pharmaceutical Group Inc. (hereinafter refe

Stock Code: 000513, 200513 Stock Name: S Livzon, Livzon-B Announcement No.: 2006-29 LIVZON PHARMACEUTICAL GROUP INC. 2006 THIRD QUARTERLY REPORT 1. I

丽珠医药集团股份有限公司2005年第三季度报告 1 Stock Code: 000513, 200513 Stock Name: Livzon Group, Livzon-B Announcement No.: 2005-25 LIVZON PHARMACEUTICAL GROUP INC. 20

1 Stock code: 000513, 200513 Short form of stock: Livzon Group, Livzon B No.: 2005-10 LIVZON PHARMACEUTICAL GROUP INC. 2005 FIRST QUARTERLY REPORT 1.

1 LIVZON PHARMACEUTICAL GROUP INC. Third Quarterly Report for 2003 1. Important Notice 1.1 The board of directors of the Company confirms that there

1 LIVZON PHARMACEUTICAL GROUP INC. FIRST QUARTERLY REPORT FOR 2004 (a joint stock limited company incorporated in the People’s Republic of China with

1 LIVZON PHARMACEUTICAL GROUP INC. 2003 ANNUAL REPORT I. IMPORTANT NOTICE Important Notice: The board of directors of the Livzon Pharmaceutical Group

Chapter 1 Important Notice and Table of Contents Important Notice: the Board of directors of our company guarantee that there is no false record, mis

LIVZON PHARMACEUTICAL GROUP INC. 2004 Annual Report I. IMPORTANT NOTICE Important Notice: The board of directors (“the Board”) of the Livzon Pharmace

丽珠医药集团股份有限公司2001年中期报告 2001-06-30 13:37 重要提示：本公司董事会保证本报告所载资料不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性负个别及连带责任。公司中期财务会计报告未经审计。 一、公司简介 （一）公司法定中文名称：丽珠医药集团股